E-3030 is a novel and potent peroxisome proliferator-activated receptor (PPAR) agonist with the potential to be used the treatment of various metabolic dysfunctions in type 2 diabetes such as dyslipidemia, hyperglycemia, hyperinsulinemia, and impaired glucose disposal

纯度：≥98%

CAS：478926-45-3